With the 2020 elections looming though, and lawmakers across the country drafting legislation aimed at curbing price increases, some companies are carefully examining the landscape as they approach pricing.

Over the last few years, there has appeared to be big interest on the part of biopharma in leveraging artificial intelligence (AI) and machine learning to improve trial design and speed up drug development. Another related category is digital therapeutics (DTx), which the Digital Therapeutics Alliance says, “deliver evidence-based therapeutic interventions to patients that are driven by high quality software programs to prevent, manage or treat a broad spectrum of physical, mental and behavioral conditions.”

South San Francisco-based Veracyte entered a multi-year partnership with AstraZeneca’s hematology research and development unit, Acerta Pharma.

BioSpace spoke to leaders from various corners of the industry who provided their insights into what 2020 is likely to hold for their particular sphere.

2019 marked yet another series of interesting, exciting and occasionally puzzling stories coming out of the biopharma industry. BioSpace breaking news writers, Alex Keown and Mark Terry, picked their top 10 stories of the year.

Tokyo-based Astellas Pharma announced plans to acquire San Francisco-based Audentes Therapeutics for $60 per share in cash, representing a total equity value of about $3 billion.

In light of the Thanksgiving season, here are six things about biopharma that the industry is thankful for.

Some analysts are checking their crystal balls to get an idea if 2020 will be a busy year for investors, and the early thinking on biotech is yes.

Bristol-Myers Squibb announced the completed acquisition of Celgene following the receipt of regulatory approval from all government authorities required by the merger agreement and, as announced in April 2019, approval by the companies’ stockholders.

Indianapolis-based Eli Lilly announced the closing of the company’s Surrey, U.K.-based Erl Wood neuroscience research center by the end of 2020, affecting 270 staffers.